Almost every medical assistance provider will tell you they have doctors and nurses in-house. It has become table stakes, and as a differentiator it has stopped meaning very much. The question worth asking a prospective partner is sharper: on a live case, who actually makes the decision?
There is a real difference between clinicians being available and clinicians being in charge.
Available versus accountable
In a clinically-staffed model, coordinators run the case and escalate to a clinician when something looks difficult. The clinical input is real but intermittent, and accountability is diffuse. In a clinically-led model, a named clinical lead owns the case. The clinical judgement sits at the centre of every material decision, from triage to treatment pathway to the mode and timing of repatriation, and one person is accountable for it.
For an insurer, that changes what you can rely on. You are not hoping the right question got escalated. The clinical view is the default, not the exception.
Why it matters more now
The market is shifting from reactive claims handling towards proactive, pre-claim clinical intelligence: engaging before the treatment, not after the bill. That shift only works if clinicians are driving the case in real time. You cannot influence a treatment pathway you are only reviewing retrospectively.
Defensibility follows from it
When decisions are clinically led and recorded as they are made, defensibility comes for free. Ask why a patient was moved when they were, or why a particular pathway was chosen, and there is a clinician’s reasoning on the record, not an after-the-fact rationalisation. For high-acuity and high-value cases, that is exactly the assurance insurers and their regulators are looking for.
Employing clinicians is necessary. Letting them lead is what actually changes the outcome, and the cost.